Tempest Therapeutics
Stock Forecast, Prediction & Price Target
Tempest Therapeutics Financial Estimates
Tempest Therapeutics Revenue Estimates
Tempest Therapeutics EBITDA Estimates
Tempest Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $17.85M Low: $17.85M High: $17.85M avg. 0% | Avg: $57.81M Low: $57.81M High: $57.81M avg. 223.84% | Avg: $25.3M Low: $25.3M High: $25.3M avg. -56.24% |
Net Income
% change YoY
| $-29.55M N/A | $-36.77M -24.46% | $-29.49M 19.81% | Avg: $-42.07M Low: $-40.23M High: $-9.86M avg. -42.67% | Avg: $-57.51M Low: $-63.05M High: $-9.40M avg. -36.68% | Avg: $-30.63M Low: $-30.63M High: $-30.63M avg. 46.72% | Avg: $-14.33M Low: $-14.33M High: $-14.33M avg. 53.20% |
EBITDA
% change YoY
| $-26.64M N/A | $-34.09M -27.94% | $-28.77M 15.59% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$7.8 N/A | -$3.18 59.23% | -$1.91 39.93% | Avg: -$1.6 Low: -$2.61 High: -$0.64 avg. 16.05% | Avg: -$2.14 Low: -$4.09 High: -$0.61 avg. -33.22% | Avg: -$1.99 Low: -$1.99 High: -$1.99 avg. 6.95% | Avg: -$0.93 Low: -$0.93 High: -$0.93 avg. 53.20% |
Operating Expenses
% change YoY
| $26.98M N/A | $34.64M 28.36% | $29.15M -15.82% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Tempest Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 5.14% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -40.23M, average is -42.07M and high is -9.86M.
What is Tempest Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 41.90% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Tempest Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.74% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$2.61, average is -$1.6 and high is $-0.64.